CVS Health (CVS) Q3 GAAP EPS $1.68; raises full-year guidance
Open the sourceReported by PR Newswire, prnewswire.com, 4 November 2026, by PR Newswire
65Impact 65 of 100, notable
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
The company generated $15.3 billion in cash flow from operations year to date and raised its full-year 2026 GAAP diluted EPS guidance to at least $6.98. The results and guidance increase signal stronger-than-expected performance across the healthcare conglomerate's operations. Investors will watch whether the raised outlook holds through the remainder of the year and how upcoming quarters reflect the drivers behind the improved cash generation.
Muhabbit's AI wrote this summary in its own words from PR Newswire's report. It can get details wrong, so check the source.
Named in this story
A linked name opens that asset's sentiment page.